NCT04133532View on ClinicalTrials.gov

Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy

PHASE4CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 5, 2020

Primary Completion Date

February 23, 2023

Study Completion Date

February 23, 2023

Conditions
Hypertrophic Cardiomyopathy
Interventions
DRUG

Metoprolol

metoprolol 50 mg daily for three months

Trial Locations (1)

15000

Motol University Hospital, Prague

All Listed Sponsors
lead

University Hospital, Motol

OTHER

NCT04133532 - Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy | Biotech Hunter | Biotech Hunter